Table 2 The baseline characteristics, univariate and multivariate cox analysis.
Characteristics | Univariate Cox | Multivariate Cox | ||
|---|---|---|---|---|
HR (95% CI) | p | HR (95% CI) | p | |
Race | ||||
Black | Reference | Reference | ||
Other race | 0.49 (0.25–0.97) | 0.039 | 0.42 (0.21–0.85 ) | 0.016 |
White | 0.71 (0.44–1.14) | 0.156 | 0.73 (0.44–1.2 ) | 0.214 |
Age | ||||
Elder | Reference | Reference | ||
Young | 0.28 (0.22–0.37) | < 0.001 | 0.27 (0.21–0.35 ) | < 0.001 |
Sequence number | ||||
1st of 2 or more primaries | Reference | Reference | ||
One primary only | 0.64 (0.46–0.89) | 0.007 | 0.58 (0.41–0.8 ) | 0.001 |
Marital | ||||
Married | Reference | Reference | ||
Other marital | 1.25 (0.96–1.62) | 0.091 | – | – |
Stage | ||||
Distant | Reference | Reference | ||
Localized | 0.11 (0.08–0.17) | < 0.001 | – | – |
Regional | 0.32 (0.21–0.48) | < 0.001 | – | – |
Surgery | ||||
None | Reference | Reference | ||
Yes | 0.31 (0.19–0.51) | < 0.001 | 0.28 ( 0.16–0.49 ) | < 0.001 |
Radiation | ||||
No radiation | Reference | Reference | ||
Radiation | 1.96 (1.5–2.56) | < 0.001 | 1.44 (1.07–1.94 ) | 0.016 |
Chemotherapy | ||||
No/Unknown | Reference | Reference | ||
Yes | 2.03 (1.48–2.79) | < 0.001 | 0.6 ( 0.4–0.91 ) | 0.016 |
RN examined | ||||
No examined | Reference | Reference | ||
Yes examined | 0.84 (0.64–1.09) | 0.179 | 0.54 ( 0.4–0.73 ) | < 0.001 |
T | ||||
T1 | Reference | Reference | ||
T2 | 2.76 (1.94–3.94) | < 0.001 | 2.67 (1.83–3.91) | < 0.001 |
T3 | 4.39 (3.19–6.02) | < 0.001 | 3.45 (2.32–5.12 ) | < 0.001 |
T4 | 7.57 (3.34–17.18) | < 0.001 | 1.82 (0.71–4.69 ) | 0.214 |
N | ||||
N0 | Reference | Reference | ||
N1 | 3.97 (2.91–5.41) | < 0.001 | 2.9 (1.91–4.39 ) | < 0.001 |
M | ||||
M0 | Reference | Reference | ||
M1 | 6.44 (4.41–9.42) | < 0.001 | 3.03 (1.83–5.01 ) | < 0.001 |
Primary site | ||||
Endometrium | Reference | Reference | ||
Ovary | 0.79 (0.39–1.6) | 0.509 | – | - |
